Enliven Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Burlingame, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Enliven Therapeutics, Inc. has filed 784 SEC EDGAR filings since 21 Apr 2016

SEC filing history

Showing 651-675 of 784 matching filings.

Per page
25
Current page
27
4

FORM 4 SUBMISSION

Filing date
11 Jan 2022
Reporting date
07 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91465

NEW ENTERPRISE ASSOCIATES 14, L.P. -- IMARA INC. 13DA1

Filing date
10 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jan 2022
Reporting date
04 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Jan 2022
Reporting date
30 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Dec 2021
Reporting date
27 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Dec 2021
Reporting date
09 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39247

8-K NOVEMBER

Filing date
25 Oct 2021
Reporting date
21 Oct 2021
Next action
Verify source filing
SC 13G/A File 005-91465

SC 13G/A filing

Filing date
10 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-258538

S-8

Filing date
06 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39247

8-K

Filing date
06 Aug 2021
Reporting date
06 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Jul 2021
Reporting date
16 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
23 Jul 2021
Reporting date
16 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
23 Jul 2021
Reporting date
16 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91465

SC 13D/A

Filing date
20 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Jul 2021
Reporting date
16 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Jul 2021
Reporting date
16 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-254978

424B5

Filing date
14 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39247

8-K

Filing date
14 Jul 2021
Reporting date
13 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-254978

424B5

Filing date
13 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39247

8-K

Filing date
13 Jul 2021
Reporting date
13 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Jul 2021
Reporting date
29 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Jun 2021
Reporting date
29 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .